Is iNOS beginning to smoke?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 22000003.
- Also identified by DOI 10.1016/j.cell.2011.09.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inducible nitric oxide synthase (iNOS) helps drive numerous inflammatory disorders, but its inhibition has not had therapeutic success. Now Seimetz et al. (2011) make a case for inhibiting iNOS in an effort to treat one of the world's leading causes of death-chronic obstructive pulmonary disease.